Peptic Ulcer Bleeding Clinical Trial
Official title:
Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study
The purpose of the investigators study is to investigate the factors associated with rebleeding in patients with peptic ulcer bleeding.
The investigators are performing a nationwide population based cohort study to investigate the factors associated with rebleeding in patients with peptic ulcer bleeding. The results of the investigators study should give us information about patients who are at high risk of rebleeindg and enable us to manage these patients appropriately. ;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03469167 -
Study to Evaluate Efficacy and Safety of Wound Dressing Solution Containing EGF in Patients With Peptic Ulcers Bleeding
|
N/A | |
Recruiting |
NCT02434978 -
Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding
|
N/A | |
Completed |
NCT01822600 -
The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia
|
Phase 4 | |
Completed |
NCT01591486 -
Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding
|
N/A | |
Completed |
NCT01591083 -
The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers
|
Phase 4 | |
Withdrawn |
NCT04407832 -
Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy
|
N/A |